Atlas Trials

Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study

Clinical trial NCT03903406 · UNKNOWN

Trial details

NCT number
NCT03903406
Sponsor
Multinational Center for Quality of Life Research, Russia
Status
UNKNOWN
Study type
OBSERVATIONAL
Relapsed and/or Refractory Multiple Myeloma
Start date
2019-05-01
Primary completion
2021-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.